Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

New York State Psychiatric Institute · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
depressive-symptomsketaminelong-covid
post-acute sequelae of covid-19, depressive symptoms, cognitive dysfunction, ketamine, pasc, long covid, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 829806
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.